Tender detail

Antineoplastic medicines 2026

Summary

Fakultní nemocnice Plzeň is procuring a four-year supply of medicines for the treatment of malignant diseases, comprising an estimated 12,680 doses across four lots. The lots cover medicines containing pertuzumab and trastuzumab, rituximab, entrectinib, and polatuzumab vedotin, for use in the hospital’s healthcare facilities.

Reference number
718748-2026
Buyer
Fakultní nemocnice Plzeň
Country
Czechia (CZE)
Procedure
Open procedure
CPV
33652000 Antineoplastic and immunomodulating agents
Deadline
2026-11-18
Status
Open
Contract subject
Supplies
Estimated value
244 100 000,00 CZK
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.